Business Standard

Suven Pharma stock can surge up to 19% from here; check key levels

Technical charts suggest that Suven Pharma may trade with a positive bias in the near-term, provided the stock manages to hold above these key support levels.

pharmaceutical sector, pharma sector, medicines, meds
Web Exclusive Premium

Photo: Bloomberg

Rex Cano Mumbai

Listen to This Article

Suven Pharma stock has under-performed both its benchmark NSE Smallcap index and the sectoral Nifty Pharma index so far this year. The stock has shed 13.5 per cent as against a rally of 8 per cent on the SmallCap index and a 10.5 per cent gain on the Nifty Pharma.

The stock has underperformed owing to sub-par earnings in the December quarter. Suven Pharma company posted a profit of Rs 5.24 crore for the December 2023 quarter, down 52.1 per cent when compared with a profit of Rs 10.95 crore in the corresponding quarter a year ago. Total income declined

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Apr 15 2024 | 2:22 PM IST

Explore News

To read the full story, subscribe to BS Premium now, at just Rs 249/ month.

Key stories on business-standard.com are available only to BS Premium subscribers.

Register to read more on Business-Standard.com